Artificial Intelligence (AI) in Healthcare Companies

The global Artificial Intelligence (AI) in healthcare market is forecasted to reach USD 110.61 billion by 2030 from USD 21.66 billion in 2025, at a CAGR of 38.6% during the forecast period. The rise in chronic diseases such as heart disease, stroke, diabetes, and cancer successively leads to substantial pressure on healthcare service providers to improve their operations. Advanced technologies in the healthcare industry have resulted in the generation of intricate datasets crucial for AI applications. Companies are updating their product portfolio to include artificial intelligence in their offerings. For instance, GE HealthCare, Cognizant, and others have improved their AI in healthcare capabilities to advance the overall healthcare experience. However, the resistance among medical practitioners to AI-based solutions and high implementation prices are expected to restrain the market growth.

The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation  (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC  (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), Solventum Corporation (US), Tempus (US), Viz.ai (US). These companies adopted strategies, such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions, to strengthen their market presence in the Artificial Intelligence (AI) in healthcare market.

To know about the assumptions considered for the study download the pdf brochure

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. is a leading player in the AI in the healthcare market. The company utilizes AI to deliver innovative tools across various areas, including diagnostic imaging, patient monitoring, and precision medicine. Its advanced AI-driven platforms, such as the Philips HealthSuite, facilitate the integration and analysis of extensive clinical data, which supports personalized treatment plans and improves patient outcomes. Philips focuses on organic and inorganic growth strategies to expand its market presence.

Strategic partnerships in high-potential markets and collaborations have been the key growth strategies of the company over the years. For example, in February 2025, Philips partnered with Medtronic to educate and train cardiologists and radiologists in India on advanced imaging techniques for structural heart diseases. This partnership aims to upskill 300+ clinicians in multi-modality imaging such as echocardiography (echo) and Magnetic Resonance Imaging (MRI), especially for End-Stage Renal Disease (ESRD) patients. In November 2023, Philips and NYU Langone Health partnered to focus on patient safety and outcomes. This partnership integrated innovative health technologies, including digital pathology, clinical informatics, and AI-enabled diagnostics, enabling real-time collaboration among clinicians. The company also focuses on winning contracts across several companies in the healthcare space. This helps the company expand its footprint. For instance, in September 2022, Philips and Mandaya Royal Hospital Puri (MRHP) in Jakarta underwent a digital transformation in a strategic partnership, enhancing patient-centered care and healthcare services.

Microsoft Corporation (US)

Microsoft Corporation is one of the leading providers of software & tools that include advanced AI capabilities in healthcare to improve patient outcomes, streamline operations, and drive innovation. Its Azure-based AI solutions support distinct applications such as medical imaging, genomics, and precision medicine. The company also provides healthcare-specific AI models through its Azure AI Model Catalog, which is constructed to support hospitals and research institutions in building and deploying tailored AI solutions proficiently. Moreover, the integration of Nuance's AI-powered clinical and diagnostic tools encourages its capacity to support healthcare providers in decision-making and care delivery. The company continuously brings AI capabilities to the platforms in large-scale customer models. For instance, in March 2025, the company launched Microsoft Dragon Copilot, the first unified voice AI assistant in the healthcare industry that enables clinicians to streamline clinical documentation, surface information, and automate tasks.

Microsoft Corporation has invested significantly in R&D, which has improved its product portfolio and position in the AI market. Machine Learning (ML), deep learning, Natural Language Processing (NLP), and speech processing are the key focus areas of the company in the AI in healthcare market. The company continuously invests in a series of services and computational biology projects, including research support tools for next-generation precision healthcare, genomics, immunomics, CRISPR, and cellular and molecular biologics. It has a strong global presence, with key operations supported through its Azure cloud infrastructure across regions like North America, Europe, Asia-Pacific, and the Middle East.

MARKET RANKING

The ranking of companies in the AI in healthcare market has been determined through a market share analysis conducted after thorough secondary research and validated by primary respondents. This ranking considers parameters such as revenue generated from AI in healthcare, product portfolio breadth and depth, innovation, and launches. Based on this analysis, the top players leading the market are Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), and GE HealthCare (US). These companies rely on their strong R&D capabilities, diversified product portfolio, global reach, and continuous innovation in the AI in healthcare market. Koninklijke Philips N.V. stands out in the AI in healthcare market. It utilizes AI to deliver innovative tools across various areas, including diagnostic imaging, patient monitoring, and precision medicine. Microsoft Corporation maintains a strong position due to its leader in software & tools that include advanced AI capabilities in healthcare to improve patient outcomes, streamline operations, and drive innovation. The company relies on product launches and developments to consolidate its market share in existing operational markets. It undertakes partnership and collaboration exercises with key local players in the target market to expand its presence in high-growth potential markets. This helps the company penetrate its products in a market with a limited presence. In September 2023, Microsoft Corporation (US) and Mercy (US) collaborated to enhance healthcare services using generative AI and digital technology. This collaboration involved utilizing the Microsoft Azure OpenAI Service to optimize patient care through AI-assisted communication, streamlined scheduling, and efficient information retrieval.

Related Reports:

Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com